Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When does patent expire on linzess expire?Epipen technology advances 2025?Linzess patent expirations?Droxidopa patent expiry?Generic substitute for multaq?
See the DrugPatentWatch profile for Lonsurf
Lonsurf is the brand name for trifluridine/tipiracil (also written as trifluridine–tipiracil). It combines two drugs with different roles: trifluridine is the active anti-cancer agent, and tipiracil helps keep trifluridine working longer in the body.
Trifluridine is an analogue of DNA building blocks. After it gets into cells, it gets incorporated into DNA and disrupts normal DNA function. The result is that cancer cells cannot maintain or replicate their DNA properly, which pushes them toward cell death.
Tipiracil inhibits an enzyme that would otherwise break down trifluridine too quickly. By slowing that breakdown, tipiracil increases the time that trifluridine stays available at effective levels.
Lonsurf targets tumor growth by interfering with the cancer cell’s ability to perform DNA replication and repair. That matters most in rapidly dividing cells such as colorectal cancer cells.
Because Lonsurf interferes with DNA handling, it can affect both cancer cells and normal rapidly dividing cells (which is why blood count changes like neutropenia are commonly discussed with this class of therapy).
Other Questions About Lonsurf :